Dopaminergic transmission in STOP null mice

Journal of Neurochemistry

Volumn 94, Issue 1, 2005, Pages 63-73

  Brun, Philippe ^a   Bégou, Mélina ^a   Andrieux, Annie ^b   Mouly Badina, Laurence ^a   Clerget, Magali ^a   Schweitzer, Annie ^b   Scarna, Hélène ^a   Renaud, Bernard ^a   Job, Didier ^b   Suaud Chagny, Marie Françoise ^a  

^a UNIVERSITÉ LYON 1   (France)

^b CEA GRENOBLE   (France)

Author keywords

Cytoskeleton; Dopamine; Limbic; Microtubules; Neuroleptics; Schizophrenia

Indexed keywords

AMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ANIMAL CELL; ARTICLE; CYTOSKELETON; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ELECTROCHEMISTRY; GENETIC ASSOCIATION; LIMBIC SYSTEM; LOCOMOTION; MICRODIALYSIS; MICROTUBULE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; NULL CELL; PRIORITY JOURNAL; SCHIZOPHRENIA; STIMULUS RESPONSE;

ACTION POTENTIALS; ANIMALS; ANTIPSYCHOTIC AGENTS; CIRCADIAN RHYTHM; DARKNESS; DOPAMINE; ELECTRIC STIMULATION; LIGHT; MALE; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; SYNAPTIC TRANSMISSION;

EID: 21344460474     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03166.x     Document Type: Article

References (46)

1. Abi-Dargham A., Gil R., Krystal J. et al. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761-767.
2. Andrieux A., Salin P. A., Vernet M. et al. (2002) The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev. 16, 2350-2364.
3. Bardgett M. E., Jackson J. L., Taylor B. M. and Csernansky J. G. (1998) The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology (Berl.) 135, 270-278.
4. Benoit-Marand M., Borrelli E. and Gonon F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134-9141.
5. Bert L., Robert F., Denoroy L., Stoppini L. and Renaud B. (1996) Enhanced temporal resolution for the microdialysis monitoring of catecholamines and excitatory amino acids using capillary electrophoresis with laser-induced fluorescence detection. Analytical developments and in vitro validations. J. Chromatogr. A 755, 99-111.
6. Bert L., Favale D., Jego G., Greve P., Guilloux J. P., Guiard B. P., Gardier A. M., Suaud-Chagny M. F. and Lestage P. (2004) Rapid and precise method to locate microdialysis probe implantation in the rodent brain. J. Neurosci. Meth. 140, 53-57.
7. Bosc C., Cronk J. D., Pirollet F., Watterson D. M., Haiech J., Job D. and Margolis R. L. (1996) Cloning, expression, and properties of the microtubule-stabilizing protein STOP. Proc. Natl Acad. Sci. USA 93, 2125-2130.
8. Breier A., Su T. P., Saunders R. et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl Acad. Sci. USA 94, 2569-2574.
9. Carlsson A., Waters N., Waters S. and Carlsson M. L. (2000) Network interactions in schizophrenia - therapeutic implications. Brain Res. Rev. 31, 342-349.
10. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M. and Carlsson M. L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41, 237-260.
11. Dugast C., Suaud-Chagny M. F. and Gonon F. (1994) Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience 62, 647-654.
12. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates, Academic Press, San Diego.
13. Freeman A. S. and Bunney B. S. (1987) Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res. 405, 46-55.
14. French S. J. and Totterdell S. (2004) Quantification of morphological differences in boutons from different afferent populations to the nucleus accumbens. Brain Res. 1007, 167-177.
15. Gainetdinov R. R., Mohn A. R. and Caron M. G. (2001) Genetic animal models: focus on schizophrenia. Trends Neurosci. 24, 527-533.
16. Garris P. A. and Rebec G. V. (2002) Modeling fast dopamine neurotransmission in the nucleus accumbens during behavior. Behav. Brain Res. 137, 47-63.
17. Garris P. A., Ciolkowski E. L., Pastore P. and Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084-6093.
18. Goff D. C. and Coyle J. T. (2001) The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158, 1367-1377.
19. Gonon F. G., Buda M. J. and Pujol J. F. (1984) In vivo voltammetric detection of catecholamine derivatives by means of treated carbon fiber electrodes, in Measurement of Neurotransmitter Release In Vivo (Marsden C. A., ed.), pp. 153-171. J. Wiley & Sons, Chichester.
20. Grace A. A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41, 1-24.
21. Grace A. A. and Bunney B. S. (1984a) The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4, 2877-2890.
22. Grace A. A. and Bunney B. S. (1984b) The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4, 2866-2876.
23. Guillaud L., Bosc C., Fourest-Lieuvin A., Denarier E., Pirollet F., Lafanechere L. and Job D. (1998) STOP proteins are responsible for the high degree of microtubule stabilization observed in neuronal cells. J. Cell Biol. 142, 167-179.
24. Harrison P. J. and Eastwood S. L. (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11, 508-519.
25. Jablensky A. (2004) Resolving schizophrenia's CATCH22. Nat. Genet. 36, 674-675.
26. Jamain S., Quach H., Betancur C. et al. (2003) Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34, 27-29.
27. Kiyatkin E. A. and Rebec G. V. (1998) Heterogeneity of ventral tegmental area neurons: single-unit recording and iontophoresis in awake, unrestrained rats. Neuroscience 85, 1285-1309.
28. Konradi C. and Heckers S. (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 97, 153-179.
29. Le Pen G. and Moreau J. L. (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 27, 1-11.
30. Lipska B. K. and Weinberger D. R. (1994) Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10, 199-205.
31. Lipska B. K. and Weinberger D. R. (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23, 223-239.
32. Martinez D., Slifstein M., Broft A. et al. (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 23, 285-300.
33. Mimics K., Middleton F. A., Lewis D. A. and Levitt P. (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci. 24, 479-486.
34. Miyakawa T., Leiter L. M., Gerber D. J., Gainetdinov R. R., Sotnikova T. D., Zeng H., Caron M. G. and Tonegawa S. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl Acad. Sci. USA 100, 8987-8992.
35. Morris J. A., Kandpal G., Ma L. and Austin C. P. (2003) DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 12, 1591-1608.
36. Peters J. L. and Michael A. C. (1998) Modeling voltammetry and microdialysis of striatal extracellular dopamine: the impact of dopamine uptake on extraction and recovery ratios. J. Neurochem. 70, 594-603.
37. Sabeti J., Gerhardt G. A. and Zahniser N. R. (2003) Chloral hydrate and ethanol, but not urethane, alter the clearance of exogenous dopamine recorded by chronoamperometry in striatum of unrestrained rats. Neurosci. Lett. 343, 9-12.
38. Sanghera M. K., Trulson M. E. and German D. C. (1984) Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies. Neuroscience 12, 793-801.
39. Schmitz Y., Schmauss C. and Sulzer D. (2002) Altered dopamine release and uptake kinetics in mice lacking D2 receptors. J. Neurosci. 22, 8002-8009.
40. Smith A. D. and Justice J. B. (1994) The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Meth. 54, 75-82.
41. Stefansson H., Steinthorsdottir V., Thorgeirsson T. E., Gulcher J. R. and Stefansson K. (2004) Neuregulin 1 and schizophrenia. Ann. Med. 36, 62-71.
42. Suaud-Chagny M. F. (2004) In vivo monitoring of dopamine overflow in the central nervous system by amperometric techniques combined with carbon fibre electrodes. Methods 33, 322-329.
43. Suaud-Chagny M. F., Dugast C., Chergui K., Msghina M. and Gonon F. (1995) Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. J. Neurochem. 65, 2603-2611.
44. Wightman R. M. and Haynes C. L. (2004) Synaptic vesicles really do kiss and run. Nat. Neurosci. 7, 321-322.
45. Wightman R. M. and Robinson D. L. (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82, 721-735.
46. Wightman R. M. and Zimmerman J. B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Rev. 15, 135-144.